The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Abstract
Vascular inflammation was examined as a potential mechanism of aldosterone-mediated myocardial injury in uninephrectomized rats receiving 1% NaCl-0.3% KCl to drink for 1, 2, or 4 wk and 1) vehicle, 2) aldosterone infusion (0.75 μg/h), or 3) aldosterone infusion (0.75 μg/h) plus the selective aldosterone blocker eplerenone (100 mg · kg−1· day−1). Aldosterone induced severe hypertension at 4 wk [systolic blood pressure (SBP), 210 ± 3 mmHg vs. vehicle, 131 ± 2 mmHg, P < 0.001], which was partially attenuated by eplerenone (SBP, 180 ± 7 mmHg; P < 0.001 vs. aldosterone alone and vehicle). No significant increases in myocardial interstitial collagen fraction or hydroxyproline concentration were detected throughout the study. However, histopathological analysis of the heart revealed severe coronary inflammatory lesions, which were characterized by monocyte/macrophage infiltration and resulted in focal ischemic and necrotic changes. The histological evidence of coronary lesions was preceded by and associated with the elevation of cyclooxygenase-2 (up to ∼4-fold), macrophage chemoattractant protein-1 (up to ∼4-fold), and osteopontin (up to ∼13-fold) mRNA expression. Eplerenone attenuated proinflammatory molecule expression in the rat heart and subsequent vascular and myocardial damage. Thus aldosterone and salt treatment in uninephrectomized rats led to severe hypertension and the development of a vascular inflammatory phenotype in the heart, which may represent one mechanism by which aldosterone contributes to myocardial disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
THE GENERAL ADAPTATION SYNDROME AND THE DISEASES OF ADAPTATION1
SELYE, H. (1946) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-6-2-117 · Cited by 2,287
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., & Cantor, H. (2000) · Science · doi:10.1126/science.287.5454.860 · Cited by 1,125
Jiang, Y., Beller, D. I., Frendl, G., & Graves, D. T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.8.2423 · Cited by 501
Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Khanna, K., Zuckerman, A., & Stier, C. T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.451 · Cited by 496
Self-citationAldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
Rocha, R. (2000) · Endocrinology · doi:10.1210/en.141.10.3871 · Cited by 475
Self-citationOsteopontin expression and function: Role in bone remodeling
Denhardt, D. T., & Noda, M. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+<92::aid-jcb13>3.0.co;2-a · Cited by 440
Molecular mechanisms of leukocyte recruitment in the inflammatory process
Ley, K. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00066-1 · Cited by 395
Liaw, L., Almeida, M., Hart, C. E., Schwartz, S. M., & Giachelli, C. M. (1994) · Circulation Research · doi:10.1161/01.res.74.2.214 · Cited by 393
Cyclooxygenase-1 and -2–Dependent Prostacyclin Formation in Patients With Atherosclerosis
Belton, O., Byrne, D., Kearney, D., Leahy, A., & Fitzgerald, D. J. (2000) · Circulation · doi:10.1161/01.cir.102.8.840 · Cited by 377
Rollins, B., Walz, A., & Baggiolini, M. (1991) · Blood · doi:10.1182/blood.v78.4.1112.1112 · Cited by 369
Wong, S. C. Y., Fukuchi, M., Melnyk, P., Rodger, I., & Giaid, A. (1998) · Circulation · doi:10.1161/01.cir.98.2.100 · Cited by 322
Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Zuckerman, A., & Stier, C. T. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.232 · Cited by 310
Self-citationLombès, M., Alfaidy, N., Eugene, E., Lessana, A., Farman, N., & Bonvalet, J.-P. (1995) · Circulation · doi:10.1161/01.cir.92.2.175 · Cited by 292
Reactive and reparative myocardial fibrosis in arterial hypertension in the rat
Brilla, C. G., & Weber, K. T. (1992) · Cardiovascular Research · doi:10.1093/cvr/26.7.671 · Cited by 280
Ashizawa, N., Graf, K., Do, Y. S., Nunohiro, T., Giachelli, C. M., Meehan, W. P., Tuan, T. L., & Hsueh, W. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119031 · Cited by 251
Monocyte Infiltration and Adhesion Molecules in a Rat Model of High Human Renin Hypertension
Mervaala, E. M. A., Müller, D. N., Park, J.-K., Schmidt, F., Löhn, M., Breu, V., Dragun, D., Ganten, D., Haller, H., & Luft, F. C. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.389 · Cited by 223
Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology
Delyani, J. A. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00983.x · Cited by 206
Self-citationGavras, H., Brunner, H. R., Laragh, J. H., Vaughan, E. D., Koss, M., Cote, L. J., & Gavras, I. (1975) · Circulation Research · doi:10.1161/01.res.36.2.300 · Cited by 202
Osteopontin Expression in Cardiovascular Diseasesa
GIACHELLI, C. M., LIAW, L., MURRY, C. E., SCHWARTZ, S. M., & ALMEIDA, M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44624.x · Cited by 181
Biological Determinants of Aldosterone-Induced Cardiac Fibrosis in Rats
Robert, V., Silvestre, J.-S., Charlemagne, D., Sabri, A., Trouvé, P., Wassef, M., Swynghedauw, B., & Delcayre, C. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.971 · Cited by 174
Singh, K., Balligand, J.-L., Fischer, T. A., Smith, T. W., & Kelly, R. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28471 · Cited by 172
Myocardial Osteopontin Expression Is Associated With Left Ventricular Hypertrophy
Graf, K., Yung, P. S., Ashizawa, N., Meehan, W. P., Giachelli, C. M., Marboe, C. C., Fleck, E., & Hsueh, W. A. (1997) · Circulation · doi:10.1161/01.cir.96.9.3063 · Cited by 149
Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro.
Gadeau, A., Campan, M., Millet, D., Candresse, T., & Desgranges, C. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.1.120 · Cited by 138
Vascular Aldosterone in Genetically Hypertensive Rats
Takeda, Y., Miyamori, I., Inaba, S., Furukawa, K., Hatakeyama, H., Yoneda, T., Mabuchi, H., & Takeda, R. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.45 · Cited by 132
Behr, T. M., Wang, X., Aiyar, N. V., Coatney, R. W., Li, X., Koster, P. D., Angermann, C. E., Ohlstein, E. H., Feuerstein, G., & Winaver, J. M. (2000) · Circulation · doi:10.1161/01.cir.102.11.1315 · Cited by 115
Koyanagi, M., Egashira, K., Kitamoto, S., Ni, W., Shimokawa, H., Takeya, M., Yoshimura, T., & Takeshita, A. (2000) · Circulation · doi:10.1161/01.cir.102.18.2243 · Cited by 104
Young, M. J., & Funder, J. W. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.5.e883 · Cited by 88
O'Regan, A. W., Hayden, J. M., & Berman, J. S. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.4.495 · Cited by 85
Zhou, M.-Y., Gómez-Sánchez, C. E., & Gómez-Sánchez, E. P. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00198-7 · Cited by 40
Cited by
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
“It has been demonstrated that excess aldosterone can promote vascular inflammation resulting in atherosclerosis (4-6).”
BackgroundMulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Salt Reduction to Prevent Hypertension and Cardiovascular Disease
He, F. J., Tan, M., Ma, Y., & MacGregor, G. A. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.055 · Cited by 589
Metadata
- Authors
- Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2002-11-01
- Volume
- 283
- Issue
- 5
- Pages
- H1802-H1810
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W1554565279
- Cited by
- 655
- References
- 30
- FWCI
- 21.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.